Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EPS (Weighted Average and Diluted) (2019 - 2025)

Inspire Medical Systems (INSP) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $4.58 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 298.26% to $4.58 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 through Dec 2025, up 183.24% year-over-year, with the annual reading at $4.89 for FY2025, 179.43% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $4.58 in Q4 2025 for Inspire Medical Systems, up from $0.34 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $4.58 in Q4 2025 to a low of -$0.61 in Q1 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.14 across 5 years, with a median of -$0.2 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 306.9% in 2024 and later crashed 137.5% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.08 in 2021, then skyrocketed by 262.5% to $0.13 in 2022, then soared by 292.31% to $0.51 in 2023, then surged by 125.49% to $1.15 in 2024, then skyrocketed by 298.26% to $4.58 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for INSP at $4.58 in Q4 2025, $0.34 in Q3 2025, and -$0.12 in Q2 2025.